DD01 operates differently, inducing faster and more potent hepatic fat reduction through direct glucagon activity in the liver. He particularly emphasized that, while GLP-1 agonists, including Wegovy, are already widely used to treat diabetes and obesity, data directly demonstrating improvement in liver fibrosis are limited
Its essential to note that adding blood-sugar-regulating ingredients shouldnt replace medications for diabetes but rather help manage these conditions through healthy nutrition
Wegovy has been approved by FDA along with strict diet and physical activity mainly for chronic weight management in 1 , 5 : Ozempic has been approved by FDA mainly for 2 , 5 : However, it is also prescribed off-label for weight management
Choose Bioavailability: Opt for liposomal delivery to bypass digestive degradation
Rescue therapy with other glucose-lowering agents was allowed per protocol criteria
J Clin Endocrin Metab, 91(12):5013-8